Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 4 Time course of the development of physiological changes

Published byCurtis Pitts Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 4 Time course of the development of physiological changes"— Presentation transcript:

1 Figure 4 Time course of the development of physiological changes
in relation to cognitive and motor changes in neurodegenerative syndromes Figure 4 | Time course of the development of physiological changes in relation to cognitive and motor changes in neurodegenerative syndromes. Physiological markers can develop presymptomatically and early in the disease course, thereby offering the potential to provide accurate, trackable biomarkers of disease. Further research is required to determine precisely when these changes arise in relation to cognitive and physical motor symptoms; the need to determine when changes arise is reflected by dashed lines. Ahmed, R. M. et al. (2018) Physiological changes in neurodegeneration — mechanistic insights and clinical utility Nat. Rev. Neurol. doi: /nrneurol

Download ppt "Figure 4 Time course of the development of physiological changes"

Similar presentations

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.
Nat. Rev. Neurol. doi:10/1038/nrneurol

Nat. Rev. Neurol. doi:10/1038/nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Life expectancy at birth in all countries included

Figure 3 Life expectancy at birth in all countries included
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 2 The US Centers for Disease Control and

Figure 2 The US Centers for Disease Control and
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 1 Carotid artery inflammation detected using 18F-FDG-PET

Figure 1 Carotid artery inflammation detected using 18F-FDG-PET
Figure 1 Hypothetical staging model of sporadic Alzheimer disease (AD)

Figure 1 Hypothetical staging model of sporadic Alzheimer disease (AD)
Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.

Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 4 Cerebrospinal fluid levels of neurofilament light chain

Figure 4 Cerebrospinal fluid levels of neurofilament light chain
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 2 Overview of risk factors for Parkinson disease dementia

Figure 2 Overview of risk factors for Parkinson disease dementia
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 2 The new concept of prodromal RBD

Figure 2 The new concept of prodromal RBD
Figure 2 ER stress and proteostasis in neurodegenerative diseases

Figure 2 ER stress and proteostasis in neurodegenerative diseases

Similar presentations

Ads by Google